APO RESEARCH · REPORT
Pain Management Drugs
Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.
Product & engineering
Understand the product.
Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.
This report is mainly about the drugs for pain management.
Selected research
Market Structure
Global Pain Management Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.
This report is mainly about the drugs for pain management.
The leading manufacturers in the industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13.95% and 3.92% of revenues in 2019. By region, the U.S. has the highest share of income, at 49.67 percent in 2019.
Read the full market overview
Report Includes
This report provides an overview of the global Pain Management Drugs market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pain Management Drugs and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pain Management Drugs revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pain Management Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.
Pain Management Drugs Segment by Company
GSK
Pfizer
Grunenthal
Sanofi
Bayer
AstraZeneca
Eli Lilly
Endo
Merck
Yunnan Baiyao
Teikoku Seiyaku
Teva
J&J
Assertio Therapeutics
Allergan
Pain Management Drugs Segment by Type
Generic Opioids
Branded Opioids
NSAIDs
Others
Pain Management Drugs Segment by Application
Hospitals
Drugstores
Others
Pain Management Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pain Management Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pain Management Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pain Management Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pain Management Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pain Management Drugs industry.
Chapter 3: Detailed analysis of Pain Management Drugs companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pain Management Drugsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Generic Opioids
- Branded Opioids
- NSAIDs
- Others
Applications
- Hospitals
- Drugstores
- Others
Companies covered
- GSK
- Pfizer
- Grunenthal
- Sanofi
- Bayer
- AstraZeneca
- Eli Lilly
- Endo
- Merck
- Yunnan Baiyao
- Teikoku Seiyaku
- Teva
- J&J
- Assertio Therapeutics
- Allergan
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Pain Management Drugs Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Generic Opioids
- 1.2.3 Branded Opioids
- 1.2.4 NSAIDs
- 1.2.5 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Pain Management Drugs Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospitals
- 1.3.3 Drugstores
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Pain Management Drugs Growth Trends by Region
- 1.5.1 Global Pain Management Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Pain Management Drugs Market Size by Region (2021-2026)
- 1.5.3 Pain Management Drugs Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Pain Management Drugs Market Dynamics
- 2.1 Pain Management Drugs Industry Trends
- 2.2 Pain Management Drugs Industry Drivers
- 2.3 Pain Management Drugs Industry Opportunities and Challenges
- 2.4 Pain Management Drugs Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Pain Management Drugs Revenue by Company (2021-2026)
- 3.2 Global Pain Management Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Pain Management Drugs Key Company Head office and Area Served
- 3.4 Global Pain Management Drugs Company, Product Type & Application
- 3.5 Global Pain Management Drugs Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Pain Management Drugs Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Pain Management Drugs Players Market Share by Revenue in 2025
- 3.6.3 2025 Pain Management Drugs Tier 1, Tier 2, and Tier 3
4 Pain Management Drugs Market by Type
- 4.1 Global Pain Management Drugs Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Pain Management Drugs Market Size by Type (2021-2032)
- 4.3 Global Pain Management Drugs Market Size Share by Type (2021-2032)
5 Pain Management Drugs Market by Application
- 5.1 Global Pain Management Drugs Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Pain Management Drugs Market Size by Application (2021-2032)
- 5.3 Global Pain Management Drugs Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 GSK
- 6.1.1 GSK Company Information
- 6.1.2 GSK Business Overview
- 6.1.3 GSK Pain Management Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 GSK Pain Management Drugs Product Portfolio
- 6.1.5 GSK Recent Developments
- 6.2 Pfizer
- 6.2.1 Pfizer Company Information
- 6.2.2 Pfizer Business Overview
- 6.2.3 Pfizer Pain Management Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Pfizer Pain Management Drugs Product Portfolio
- 6.2.5 Pfizer Recent Developments
- 6.3 Grunenthal
- 6.3.1 Grunenthal Company Information
- 6.3.2 Grunenthal Business Overview
- 6.3.3 Grunenthal Pain Management Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Grunenthal Pain Management Drugs Product Portfolio
- 6.3.5 Grunenthal Recent Developments
- 6.4 Sanofi
- 6.4.1 Sanofi Company Information
- 6.4.2 Sanofi Business Overview
- 6.4.3 Sanofi Pain Management Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Sanofi Pain Management Drugs Product Portfolio
- 6.4.5 Sanofi Recent Developments
- 6.5 Bayer
- 6.5.1 Bayer Company Information
- 6.5.2 Bayer Business Overview
- 6.5.3 Bayer Pain Management Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Bayer Pain Management Drugs Product Portfolio
- 6.5.5 Bayer Recent Developments
- 6.6 AstraZeneca
- 6.6.1 AstraZeneca Company Information
- 6.6.2 AstraZeneca Business Overview
- 6.6.3 AstraZeneca Pain Management Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 AstraZeneca Pain Management Drugs Product Portfolio
- 6.6.5 AstraZeneca Recent Developments
- 6.7 Eli Lilly
- 6.7.1 Eli Lilly Company Information
- 6.7.2 Eli Lilly Business Overview
- 6.7.3 Eli Lilly Pain Management Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Eli Lilly Pain Management Drugs Product Portfolio
- 6.7.5 Eli Lilly Recent Developments
- 6.8 Endo
- 6.8.1 Endo Company Information
- 6.8.2 Endo Business Overview
- 6.8.3 Endo Pain Management Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Endo Pain Management Drugs Product Portfolio
- 6.8.5 Endo Recent Developments
- 6.9 Merck
- 6.9.1 Merck Company Information
- 6.9.2 Merck Business Overview
- 6.9.3 Merck Pain Management Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Merck Pain Management Drugs Product Portfolio
- 6.9.5 Merck Recent Developments
- 6.10 Yunnan Baiyao
- 6.10.1 Yunnan Baiyao Company Information
- 6.10.2 Yunnan Baiyao Business Overview
- 6.10.3 Yunnan Baiyao Pain Management Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Yunnan Baiyao Pain Management Drugs Product Portfolio
- 6.10.5 Yunnan Baiyao Recent Developments
- 6.11 Teikoku Seiyaku
- 6.11.1 Teikoku Seiyaku Company Information
- 6.11.2 Teikoku Seiyaku Business Overview
- 6.11.3 Teikoku Seiyaku Pain Management Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Teikoku Seiyaku Pain Management Drugs Product Portfolio
- 6.11.5 Teikoku Seiyaku Recent Developments
- 6.12 Teva
- 6.12.1 Teva Company Information
- 6.12.2 Teva Business Overview
- 6.12.3 Teva Pain Management Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Teva Pain Management Drugs Product Portfolio
- 6.12.5 Teva Recent Developments
- 6.13 J&J
- 6.13.1 J&J Company Information
- 6.13.2 J&J Business Overview
- 6.13.3 J&J Pain Management Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 J&J Pain Management Drugs Product Portfolio
- 6.13.5 J&J Recent Developments
- 6.14 Assertio Therapeutics
- 6.14.1 Assertio Therapeutics Company Information
- 6.14.2 Assertio Therapeutics Business Overview
- 6.14.3 Assertio Therapeutics Pain Management Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Assertio Therapeutics Pain Management Drugs Product Portfolio
- 6.14.5 Assertio Therapeutics Recent Developments
- 6.15 Allergan
- 6.15.1 Allergan Company Information
- 6.15.2 Allergan Business Overview
- 6.15.3 Allergan Pain Management Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Allergan Pain Management Drugs Product Portfolio
- 6.15.5 Allergan Recent Developments
7 North America
- 7.1 North America Pain Management Drugs Market Size (2021-2032)
- 7.2 North America Pain Management Drugs Market Size by Type
- 7.2.1 North America Pain Management Drugs Market Size by Type (2021-2026)
- 7.2.2 North America Pain Management Drugs Market Size by Type (2027-2032)
- 7.2.3 North America Pain Management Drugs Market Share by Type (2021-2032)
- 7.3 North America Pain Management Drugs Market Size by Application
- 7.3.1 North America Pain Management Drugs Market Size by Application (2021-2026)
- 7.3.2 North America Pain Management Drugs Market Size by Application (2027-2032)
- 7.3.3 North America Pain Management Drugs Market Share by Application (2021-2032)
- 7.4 North America Pain Management Drugs Market Size by Country
- 7.4.1 North America Pain Management Drugs Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Pain Management Drugs Market Size by Country (2021-2026)
- 7.4.3 North America Pain Management Drugs Market Size by Country (2027-2032)
- 7.4.4 North America Pain Management Drugs Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Pain Management Drugs Market Size (2021-2032)
- 8.2 Europe Pain Management Drugs Market Size by Type
- 8.2.1 Europe Pain Management Drugs Market Size by Type (2021-2026)
- 8.2.2 Europe Pain Management Drugs Market Size by Type (2027-2032)
- 8.2.3 Europe Pain Management Drugs Market Share by Type (2021-2032)
- 8.3 Europe Pain Management Drugs Market Size by Application
- 8.3.1 Europe Pain Management Drugs Market Size by Application (2021-2026)
- 8.3.2 Europe Pain Management Drugs Market Size by Application (2027-2032)
- 8.3.3 Europe Pain Management Drugs Market Share by Application (2021-2032)
- 8.4 Europe Pain Management Drugs Market Size by Country
- 8.4.1 Europe Pain Management Drugs Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Pain Management Drugs Market Size by Country (2021-2026)
- 8.4.3 Europe Pain Management Drugs Market Size by Country (2027-2032)
- 8.4.4 Europe Pain Management Drugs Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Pain Management Drugs Market Size (2021-2032)
- 9.2 China Pain Management Drugs Market Size by Type
- 9.2.1 China Pain Management Drugs Market Size by Type (2021-2026)
- 9.2.2 China Pain Management Drugs Market Size by Type (2027-2032)
- 9.2.3 China Pain Management Drugs Market Share by Type (2021-2032)
- 9.3 China Pain Management Drugs Market Size by Application
- 9.3.1 China Pain Management Drugs Market Size by Application (2021-2026)
- 9.3.2 China Pain Management Drugs Market Size by Application (2027-2032)
- 9.3.3 China Pain Management Drugs Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Pain Management Drugs Market Size (2021-2032)
- 10.2 Asia Pain Management Drugs Market Size by Type
- 10.2.1 Asia Pain Management Drugs Market Size by Type (2021-2026)
- 10.2.2 Asia Pain Management Drugs Market Size by Type (2027-2032)
- 10.2.3 Asia Pain Management Drugs Market Share by Type (2021-2032)
- 10.3 Asia Pain Management Drugs Market Size by Application
- 10.3.1 Asia Pain Management Drugs Market Size by Application (2021-2026)
- 10.3.2 Asia Pain Management Drugs Market Size by Application (2027-2032)
- 10.3.3 Asia Pain Management Drugs Market Share by Application (2021-2032)
- 10.4 Asia Pain Management Drugs Market Size by Country
- 10.4.1 Asia Pain Management Drugs Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Pain Management Drugs Market Size by Country (2021-2026)
- 10.4.3 Asia Pain Management Drugs Market Size by Country (2027-2032)
- 10.4.4 Asia Pain Management Drugs Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Pain Management Drugs Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Pain Management Drugs Market Size by Type
- 11.2.1 South America, Middle East & Africa Pain Management Drugs Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Pain Management Drugs Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Pain Management Drugs Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Pain Management Drugs Market Size by Application
- 11.3.1 South America, Middle East & Africa Pain Management Drugs Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Pain Management Drugs Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Pain Management Drugs Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Pain Management Drugs Market Size by Country
- 11.4.1 South America, Middle East & Africa Pain Management Drugs Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Pain Management Drugs Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Pain Management Drugs Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Pain Management Drugs Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst